OVERVIEW

Building the Bridge: Targeted Education to Address Knowledge Gaps Related to Drug-to-Drug Interactions When Treating Outpatients with COVID-19 is organized by Nurse Practitioner Associates for Continuing Education (NPACE).

Expiration Date: June 30th, 2025

Description:
The overall goal of this program is to deliver targeted educational interventions to (1) improve health outcomes among outpatients with COVID-19 by building skills, knowledge, and competencies of providers that serve them, and (2) address provider knowledge gaps related to Drug-to-Drug Interactions (DDIs) in COVID-19 treatment.

Learning Objectives:
After taking part in this educational activity, participants should be better able to:

  • Improvement in their ability to identify disparity gaps in treatment, management, and DDI in outpatients with COVID-19
  • Greater confidence in their ability to assess and manage outpatients with COVID-19 for DDIs
  • Enhanced understanding of the National COVID-19 Treatment Guidelines for outpatients with COVID-19
Credits

Designation Statement
NPACE designates this educational activity for a maximum of 1.00 contact hours, of which 1.0 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.

Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.

  • 1 Contact Hours
  • TARGET AUDIENCE

    PhysicianNursingPharmacistInfectious Diseases Physician

    SPECIALITIES

    Infectious DiseasePharmacology

    RELATED ONLINE COURSES